PharmaDispatch - PharmaDispatch

Latest News
Exclusive: PBAC targets lung cancer in first pan-tumour outcome

The PBAC has actioned one proposed radical change to how the PBS funds cancer therapies in an outcome of the review of pan-tumour medicines.

Latest News Australia delivers world first for new cancer therapy December 12, 2018
Australia has become the first country to approve a new first-in-class therapy for multiple myeloma patients.
Latest News Bridge Program participants visit US-based companies December 12, 2018
Four participants in the industry-backed Bridge Program have spent recent days in the US visiting the headquarters of three major pharmaceutical companies following a competitive pitching competition.
Latest News TGA approves new Opdivo dosing schedule December 12, 2018
Bristol-Myers Squibb has welcomed TGA approval of its application to update the OPDIVO (nivolumab) dosing schedule.
Latest News Companies share their approach to workplace flexibility December 11, 2018
PharmaDispatch approached a number of companies for information on their policies and approach to workplace flexibility. This is what they said.
Latest News Hitting a nerve on 'workplace flexibility' December 11, 2018
Yesterday's two stories about the Pharma Australia Gender Equity initiative triggered a remarkable response from the PharmaDispatch readership.
Latest News Updated healthcare atlas highlights medicine use December 11, 2018
The 'Third Australian Atlas of Healthcare Variation' has revealed what it describes as underuse of evidence-based care and overuse of inappropriate care, including in relation to medicines.
Latest News Melbourne company joins the antimicrobial challenge December 11, 2018
Melbourne-based Opal BioSciences has joined the US government's Antimicrobial Resistance Challenge by committing to work on the development of urgently needed new anti-infective treatments for life-threatening and hard-to-treat infections.
Latest News Pfizer officially makes Sydney CBD its new home December 10, 2018
Pfizer Australia today officially unveiled its new state of the art office at Barrack Place in the Sydney CBD.
Latest News AbbVie's Kirsten O'Doherty: Judge people on output, not attendance December 10, 2018
The industry's challenge is to improve the number of women in senior leadership roles, says AbbVie managing director and Medicines Australia board member Kirsten O'Doherty.
Latest News The facts on workplace flexibility December 10, 2018
AbbVie's Kirsten O'Doherty and AstraZeneca's Kimberly Elliott both highlighted the importance of workplace flexibility in separate interviews with PharmaDispatch about the gender equity-focused PAGE initiative. What are the facts?
Latest News Who understands and will pay for the 'combined view'? December 10, 2018
PharmaDispatch is publishing the 'combined view' model presented by Department of Health officials at last week's pricing forum in Sydney.
Latest News PharmaDispatch 2019: Renewed focus on supply chain December 6, 2018
DHL's Saul Resnick, leading pharmacy compounder David Slade and Mundipharma's managing director Jane Orr, are the latest to confirm their participation in PharmaDispatch 2019.
Latest News Get ready for 2019 'Pharma 2 Peak Kosi Challenge' December 7, 2018
Pharmaceutical companies will gather next week for the official launch of the 2019 Rare Cancers Australia 'Pharma 2 Peak Kosi Challenge' cup.
Latest News Hurdles mount for supply chain payment reform December 7, 2018
The pharmaceutical sector has made it clear to the government that reform of the supply chain payment system by July 2019 is not practical regardless of the chosen model.

News of the Day

Latest Video

Most Read

New Stories